Here’s how much £1k invested in the Standard Life Aberdeen share price a year ago would be worth today

Rupert Hargreaves follows up on his Standard Life Aberdeen share price tip he put forward at the beginning of 2019.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In 2018, the Standard Life Aberdeen (LSE: SLA) share price slumped 43.6% making the stock one of the worst performers in the FTSE 100.

However, despite this performance, I highlighted Standard Life as one of my top buys for 2019 at the beginning of this year. While the rest of the market was selling shares in the asset manager, I was attracted to its 9.7% dividend yield and track record of creating value for shareholders as well as its hidden value on the balance sheet.

Considering these factors, I was prepared to look past the group’s near-term headwinds and concentrate on its long-term potential. 

Happy returns

As it turns out, I made the right decision to buy Standard Life at the beginning of 2019. Over the past 12 months, the shares have produced a total return of 41.1%, outperforming the FTSE 100 total return index by a wide margin. This index has returned just 15% over the past 12 months. These figures suggest that £1,000 invested in the company at the end of 2018 would be worth £1,441 today.

I think this performance can continue. 2019 has been something of a transformational year for the firm as it has progressed with the integration of Aberdeen Asset Management. 

The benefits of the merger are now really starting to flow through. Earlier this year the company declared that the integration process was 75% complete and that savings would total £400m by the end of 2020. City analysts are forecasting a 3% increase in earnings per share for 2020. 

That’s not to say that the company is entirely out of the woods yet. Standard Life is still grappling with the challenges that led investors to exit in droves in 2018. These include outflows from its leading Global Absolute Return Strategy, which was once the largest fund in the UK market.

The fund managed £20.7bn in February 2018, but now has assets of just over £6bn. Outflows from the group’s property fund have also spiked this year. 

Hidden value

These trends are concerning, but the asset management business only accounts for around 22% of the group’s value, according to City analysts. The company’s non-core businesses, such as its Indian life insurance joint venture, and its holding in FTSE 100 peer Phoenix, account for most of its worth. In my view, this is where the real value lies. 

If you take these assets away from the rest of the business, analyst estimates suggest the underlying asset management business is trading at a single-digit P/E multiple. As a result, I think that any improvement in underlying profitability at this part of the company could lead to a big jump in the share price. 

That’s why I’m still a buyer of the Standard Life share price, even after its recent performance. As well as the hidden value on the balance sheet, there’s also that 6.6% dividend yield to look forward to, so investors will be paid to wait for a recovery.

Rupert Hargreaves owns shares in Standard Life Aberdeen. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »